Procter & Gamble Hygiene and Health Care (500459) Q3 25/26 earnings summary

Executive summary

• Unaudited financial results for the quarter and nine months ended December 31, 2025, were approved and published following a Board meeting on January 30, 2026.

• Interim dividend of Rs. 195 per equity share declared, including a one-time special dividend of Rs. 25 per share, to be paid by February 27, 2026.

Financial highlights

• Revenue from operations for the quarter ended December 31, 2025, was Rs. 125,991 lakhs, up from Rs. 114,885 lakhs in the previous quarter and Rs. 124,625 lakhs in the same quarter last year.

• Profit before tax for the quarter was Rs. 40,204 lakhs, compared to Rs. 28,178 lakhs in the previous quarter and Rs. 36,413 lakhs year-over-year.

• Net profit for the quarter was Rs. 30,146 lakhs, up from Rs. 21,403 lakhs in the previous quarter and Rs. 26,207 lakhs in the same quarter last year.

• Basic and diluted EPS for the quarter were Rs. 92.87, compared to Rs. 64.65 in the previous quarter and Rs. 82.74 year-over-year.

Outlook and guidance

• Management does not expect material financial impact from the implementation of new Labour Codes, as the current salary structure aligns with regulatory requirements.

• The company continues to monitor regulatory developments and will adjust as needed.